Ameriprise Financial, Inc.AMP
NYSE • Financial Services
$452.19
P/E
12.43
PEG
0.01
FCF Yield
—
Rev Growth YoY
+549.0% YoY
Gross Margin
5267.0%
Health Score
5/10
D/E Ratio
6.05
Confidence
LOW
Business Snapshot
Ameriprise Financial is a large-scale diversified financial services company operating primarily in asset management, wealth management, and retirement solutions for both retail and institutional clients in the United States and globally. The company competes in the highly competitive asset management and financial advisory space, serving millions of clients through its Ameriprise Financial Services and Columbia Threadneedle Investments platforms. Based on available valuation ratios and industry context, AMP is consistent with a large-cap classification, though a precise market capitalisation figure is not available in this data set.
Financial Health
**Score: 5/10** Ameriprise presents a genuinely mixed financial picture. On the positive side, the reported net margin stands at an extraordinary 1,884.0%, which — while almost certainly reflective of non-recurring items or accounting adjustments (such as fair value movements common in financial services) — signals that the bottom line is not under immediate stress...
Risk Assessment
- **LEVERAGE:** Debt/equity of 6.05x is highly elevated, amplifying downside exposure in any credit tightening or market downturn environment. - **DATA INTEGRITY:** Gross margin of 5,267% and net margin of 1,884% are economically implausible for an asset manager and almost certainly reflect one-time distortions, base-effect anomalies, or accounting reclassifications — making earnings quality difficult to assess. - **CASH FLOW VISIBILITY:** Free cash flow is unavailable, preventing any assessment of the company's ability to service its debt load or sustain capital returns to shareholders. - **TECHNICAL DETERIORATION:** The stock is trading below both its 50-day and 200-day moving averages, with MACD in a bearish configuration and a confirmed "death cross" pattern — a signal historically associated with continued near-term price weakness. - **PRICE DISCOUNT TO 52-WEEK HIGH:** At $452.19, the stock sits 17.8% below its 52-week high of $550.18, indicating the market has materially re-rated the stock downward from recent peaks without a visible fundamental catalyst from the available data. ---...